Advances in cancer drug discovery - a British association for cancer research meeting.
The Advances in Cancer Drug Discovery meeting, organized by the British Association for Cancer Research, attracted approximately 140 delegates from industry and academia, representing a diverse spectrum from both chemical and biological sciences backgrounds. A wide range of topics was discussed, including the identification and validation of new cancer drug targets, cancer drug design, screening, new technologies, novel approaches in cancer drug discovery, and the development of preclinical and clinical biomarkers. This report focuses on the identification and development of new therapeutic agents and the role of biomarkers in drug evaluation.
Westwell
Andrew D
AD
Welsh School of Pharmacy, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff, CF10 3NB, UK. westwella@cf.ac.uk
D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology* / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D004260:DNA Repair / Q000187:drug effects; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010601:Pharmacology, Clinical / Q000639:trends
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D004791:Enzyme Inhibitors